Hello. It's Mark Kris from Memorial Sloan Kettering. Recently, I presented information about the published trials of neoadjuvant nivolumab chemotherapy vs chemotherapy, showing robust, disease-free ...

In early-stage HER2-positive breast cancer, patients who were sensitive to neoadjuvant HER2-targeted treatment with chemotherapy were more likely to be younger and have tumors with more advanced ...

Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update The working group recommends a preferred definition of pathologic complete response (pCR) as the absence ...